Histological and histochemical study of oxidative stress effects on pancreatic tissue in diabetic rats and the protective role of Nigella sativa extract

Authors

DOI:

https://doi.org/10.31210/spi2026.29.01.33

Keywords:

diabetes mellitus, streptozotocin, oxidative stress, pancreatic histology, Nigella sativa, islets of Langerhans, antioxidants, histochemistry

Abstract

Diabetes mellitus (DM) is a chronic metabolic disease characterized by severe hyperglycemia resulting from defects in insulin secretion or action, with oxidative stress driving its pathogenesis via pancreatic beta-cell destruction. This study investigated histopathological and histochemical alterations in the pancreatic tissue of streptozotocin-induced diabetic rats and evaluated the cytoprotective efficacy of a Nigella sativa (black seed) aqueous extract. Forty adult male Wistar albino rats (200–250 g) were randomly assigned to four groups (n = 10 each): Group I (Normal Control), Group II (Diabetic Control; induced with a single i.p. injection of streptozotocin, 60 mg/kg), Group III (diabetic rats treated orally with 400 mg/kg/day of Nigella sativa extract for 8 weeks), and Group IV (normal rats treated with the extract). Pancreatic tissues were processed for Hematoxylin and Eosin (H&E), Periodic Acid-Schiff (PAS), Masson's trichrome, Gomori's aldehyde fuchsin, and immunohistochemical detection of insulin and glucagon, alongside tissue oxidative stress marker quantification (MDA, SOD, CAT, GPx). Streptozotocin-treated rats exhibited severe histopathological alterations (P<0.001), including a 75.0 % reduction in islet density, a 66.6 % decrease in islet cross-sectional area, extensive periinsular and interlobular fibrosis, and severe depletion of both PAS-positive glycoproteins and insulin-immunoreactive beta cells. These structural changes directly correlated with a significant elevation in malondialdehyde (MDA) levels (P<0.001) and a concurrent decline in SOD, CAT, and GPx antioxidant activities (P<0.001). Daily oral administration of Nigella sativa extract in Group III significantly attenuated these microstructural and biochemical abnormalities (P<0.001). The treatment preserved near-normal islet architecture, reduced connective tissue deposition more than twofold, and drove a substantial 2.1-fold recovery in functional insulin expression relative to the untreated diabetic group. These findings demonstrate that chronic oxidative stress induces profound structural and histochemical damage to both the endocrine and exocrine pancreas, whereas Nigella sativa extract exerts a potent cytoprotective effect mediated by its antioxidant, anti-inflammatory, and anti-fibrotic properties, confirming its therapeutic potential as an effective complementary strategy in managing diabetes mellitus and preventing secondary pancreatic complications.

References

1. Abukhader, M. (2012). The effect of route of administration in thymoquinone toxicity in male and female rats. Indian Journal of Pharmaceutical Sciences, 74 (3), 195. https://doi.org/10.4103/0250-474x.106060

2. Ahmad, A., Husain, A., Mujeeb, M., Khan, S. A., Najmi, A. K., Siddique, N. A., Damanhouri, Z. A., & Anwar, F. (2013). A review on therapeutic potential of Nigella sativa: A miracle herb. Asian Pacific Journal of Tropical Biomedicine, 3 (5), 337–352. https://doi.org/10.1016/s2221-1691(13)60075-1

3. Al-Logmani, A., & Zari, T. (2009) Effects of Nigella sativa L. and Cinnamomum zeylanicum Blume oils on some physiological parameters in streptozotocin-induced diabetic rats. Boletín Latinoamericano y del Caribe de Plantas Medicinales y Aromáticas, 8, 86–96.

4. Apte, M. V., & Wilson, J. S. (2012). Dangerous liaisons: Pancreatic stellate cells and pancreatic cancer cells. Journal of Gastroenterology and Hepatology, 27 (s2), 69–74. https://doi.org/10.1111/j.1440-1746.2011.07000.x

5. Bancroft, J. D., & Gamble, M. (Eds.). (2008). Theory and practice of histological techniques (6th ed.). Churchill Livingstone.

6. Datau, E. A., Wardhana, Surachmanto, E. E., Pandelaki, K., Langi, J. A., & Fias. (2010). Efficacy of Nigella sativa on serum free testosterone and metabolic disturbances in central obese male. Acta Medica Indonesiana, 42 (3), 130–134.

7. Eleazu, C. O., Eleazu, K. C., Chukwuma, S., & Essien, U. N. (2013). Review of the mechanism of cell death resulting from streptozotocin challenge in experimental animals, its practical use and potential risk to humans. Journal of Diabetes & Metabolic Disorders, 12 (1), 60. https://doi.org/10.1186/2251-6581-12-60

8. Giacco, F., & Brownlee, M. (2010). Oxidative stress and diabetic complications. Circulation Research, 107 (9), 1058–1070. https://doi.org/10.1161/circresaha.110.223545

9. Harborne, J. B. (1998). Phytochemical methods: A guide to modern techniques of plant analysis (3rd ed.). Chapman & Hall.

10. International Diabetes Federation. (2021). IDF diabetes atlas (10th ed.). International Diabetes Federation. https://www.diabetesatlas.org

11. Junod, A., Lambert, A. E., Stauffacher, W., & Renold, A. E. (1969). Diabetogenic action of streptozotocin: relationship of dose to metabolic response. Journal of Clinical Investigation, 48 (11), 2129–2139. https://doi.org/10.1172/jci106180

12. Lenzen, S. (2007). The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia, 51 (2), 216–226. https://doi.org/10.1007/s00125-007-0886-7

13. Robertson, R. P. (2004). Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. Journal of Biological Chemistry, 279 (41), 42351–42354. https://doi.org/10.1074/jbc.r400019200

14. Srinivasan, K., & Ramarao, P. (2007). Animal models in type 2 diabetes research: an overview. Indian Journal of Medical Research, 125 (3), 451–472.

15. Awwaliya, E., Salim, H. M., Muhammad, D. S., Romadhani, D. F., & Nisaussholihah, N. (2019). Hypoglycemic effects of extract Nigella Sativa in diabetic mice model. International Islamic Medical Journal, 1 (1), 28–31. https://doi.org/10.33086/iimj.v1i1.1327

16. Unger, R. H., & Cherrington, A. D. (2012). Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover. Journal of Clinical Investigation, 122 (1), 4–12. https://doi.org/10.1172/jci60016

17. Van Belle, T. L., Coppieters, K. T., & Von Herrath, M. G. (2011). Type 1 diabetes: Etiology, immunology, and therapeutic strategies. Physiological Reviews, 91 (1), 79–118. https://doi.org/10.1152/physrev.00003.2010

18. Wiernsperger, N. (2003). Oxidative stress as a therapeutic target in diabetes: revisiting the controversy. Diabetes & Metabolism, 29 (6), 579–585. https://doi.org/10.1016/s1262-3636(07)70072-1

19. Gray, J. P., Zayasbazan Burgos, D., Yuan, T., Seeram, N., Rebar, R., Follmer, R., & Heart, E. A. (2016). Thymoquinone, a bioactive component of Nigella sativa, normalizes insulin secretion from pancreatic β-cells under glucose overload via regulation of malonyl-CoA. American Journal of Physiology-Endocrinology and Metabolism, 310 (6), E394–E404. https://doi.org/10.1152/ajpendo.00250.2015

20. D’Alessio, D. (2011). The role of dysregulated glucagon secretion in type 2 diabetes. Diabetes, Obesity and Metabolism, 13 (s1), 126–132. https://doi.org/10.1111/j.1463-1326.2011.01449.x

Downloads

Published

2026-06-25

How to Cite

Nada, R. H., Mahdi, E. M., Abas, S. F. H., & Hameed, B. K. (2026). Histological and histochemical study of oxidative stress effects on pancreatic tissue in diabetic rats and the protective role of Nigella sativa extract. Scientific Progress & Innovations, 29(1), 206–217. https://doi.org/10.31210/spi2026.29.01.33